Conavi Medical Corp.
CNVI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.41% | -77.45% | 60.67% | -91.68% | -18.21% |
| Total Depreciation and Amortization | 55.05% | -3.21% | -6.09% | -9.41% | 4.19% |
| Total Amortization of Deferred Charges | -9.68% | 8.14% | -30.08% | -- | -- |
| Total Other Non-Cash Items | -88.63% | 117.27% | -202.77% | 365.22% | 61.69% |
| Change in Net Operating Assets | 227.79% | -498.94% | 196.64% | 81.73% | -330.49% |
| Cash from Operations | 60.14% | -58.62% | 15.87% | 35.51% | -120.60% |
| Capital Expenditure | -8,741.67% | 83.26% | -168.75% | -86.05% | 77.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 168.42% | 10.18% | -27.71% | -- | 100.00% |
| Cash from Investing | -244.40% | 25.29% | -43.25% | -1,588.37% | 81.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.81% | -1.86% | -61.13% | 29.67% | -14.75% |
| Issuance of Common Stock | -89.23% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.35% | -- |
| Cash from Financing | -104.72% | 2,237.02% | -31.98% | -102.03% | 5,108.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.34% | 172.50% | 11.59% | -153.35% | 362.19% |